DAIICHI SANKYO EUROPE GMBH
Patent Applications and Registrations
Patent applications and USPTO patent grants for DAIICHI SANKYO EUROPE GMBH.The latest application filed is for "anti-her3 antibody-drug conjugate".
- DAIICHI SANKYO EUROPE GMBH - Munich DE
- Daiichi Sankyo Europe GmbH - Munchen DE
- DAIICHI SANKYO EUROPE GMBH - MUENCHEN DE
Trademarks
| Patent | Date |
|---|---|
| HER3 inhibitor for modulating radiosensitivity Grant 11,351,259 - Wheeler , et al. June 7, 2 | 2022-06-07 |
| Anti-her3 Antibody-drug Conjugate App 20220172420 - HETTMANN; Thore ; et al. | 2022-06-02 |
| Anti-HER3 antibody-drug conjugate Grant 11,298,359 - Hettmann , et al. April 12, 2 | 2022-04-12 |
| Antibodies directed to HER-3 and uses thereof Grant 11,267,900 - Rothe , et al. March 8, 2 | 2022-03-08 |
| Combination of human anti-FGFR4 antibody and Sorafenib Grant 10,995,143 - Abraham , et al. May 4, 2 | 2021-05-04 |
| Combination Of Anti-fgfr4-antibody And Bile Acid Sequestrant App 20210023211 - Abraham; Reimar ; et al. | 2021-01-28 |
| Combination of anti-FGFR4-antibody and bile acid sequestrant Grant 10,765,738 - Abraham , et al. Sep | 2020-09-08 |
| Her3 Inhibitor For Modulating Radiosensitivity App 20190388540 - WHEELER; Deric L. ; et al. | 2019-12-26 |
| Antibodies Directed To Her-3 And Uses Thereof App 20190263930 - ROTHE; MIKE ; et al. | 2019-08-29 |
| Anti-HER3 antibody-drug conjugate Grant 10,383,878 - Hettmann , et al. A | 2019-08-20 |
| Activated HER3 as a marker for predicting therapeutic efficacy Grant 10,365,283 - Rothe , et al. July 30, 2 | 2019-07-30 |
| HER3 inhibitor for modulating radiosensitivity Grant 10,357,566 - Wheeler , et al. July 23, 2 | 2019-07-23 |
| Human anti-FGFR4 antibody Grant 10,358,498 - Abraham , et al. | 2019-07-23 |
| Anti-her3 Antibody-drug Conjugate App 20190151328 - HETTMANN; Thore ; et al. | 2019-05-23 |
| Combination Of Human Anti-fgfr4 Antibody And Sorafenib App 20190048088 - Abraham; Reimar ; et al. | 2019-02-14 |
| Antibodies directed to HER-3 and uses thereof Grant 10,100,124 - Rothe , et al. October 16, 2 | 2018-10-16 |
| Material and methods for treating or preventing HER-3 associated diseases Grant 9,988,462 - Hettmann , et al. June 5, 2 | 2018-06-05 |
| Material And Methods For Treating Or Preventing Her-3 Associated Diseases App 20180134805 - HETTMANN; THORE ; et al. | 2018-05-17 |
| Material and methods for treating or preventing HER-3 associated diseases Grant 9,803,025 - Hettmann , et al. October 31, 2 | 2017-10-31 |
| Human anti-FGFR4 antibody App 20170226213 - Abraham; Reimar ; et al. | 2017-08-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 